Clinical Trials Directory

Trials / Sponsors / Seres Therapeutics, Inc.

Seres Therapeutics, Inc.

Industry · 8 registered clinical trials.

StatusTrialPhaseStarted
CompletedA Multiple Dose Study to Evaluate Safety, Tolerability, PK, and Efficacy of SER-155 in Adults Undergoing HSCT
Allogeneic Hematopoietic Stem Cell Transplantation
Phase 12021-11-24
TerminatedA Study to Assess Efficacy and Safety of SER-287 in Adults With Active Mild-to-Moderate Ulcerative Colitis
Ulcerative Colitis
Phase 22018-12-19
CompletedECOSPOR IV: An Open-Label Study Evaluating SER-109 in Recurrent Clostridioides Difficile Infection
Clostridioides Difficile Infection
Phase 32017-10-23
CompletedECOSPOR III - SER-109 Versus Placebo in the Treatment of Adults With Recurrent Clostridium Difficile Infection
Clostridium Difficile Infection
Phase 32017-07-10
CompletedSER-262 Versus Placebo in Adults With Primary Clostridium Difficile Infection to Prevent Recurrence
Clostridium Difficile Infection
Phase 12016-08-01
CompletedA Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects With Mild-to-Moder
Ulcerative Colitis
Phase 12016-01-13
CompletedSER-109 Versus Placebo to Prevent Recurrent Clostridium Difficile Infection (RCDI)
Clostridium Difficile
Phase 22015-05-01
Approved For MarketingExpanded Access Program of SER-109 in the Treatment of Adults With Recurrent Clostridioides Difficile Infectio
Clostridioides Difficile Infection
——